Humana · Off Label NCCN · US health-plan appeal rights

Off Label NCCN denied as non-formulary by Humana?

Q: How long do I have to appeal a Humana Off Label NCCN denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Non-formulary doesn't mean uncoverable. Most plans have a formulary-exception process: the appeal needs to show the formulary alternatives are inappropriate for your specific clinical situation.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Humana typically requires

Humana's specific coverage criteria for off label nccn are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Humana Oncology Pharmacy Prior Authorization Criteria (Medicare Advantage tied to CMS NCDs/LCDs)

The Humana angle on Off Label NCCN

## Why Humana Denied This Off-Label (NCCN-Supported) Drug as Non-Formulary

A non-formulary denial means the requested drug is not on Humana's approved drug list for your plan tier. For off-label oncology uses supported by the NCCN Compendium, this is one of the most commonly overturned denial categories: most states and federal rules require insurers to cover NCCN-listed oncology drugs regardless of formulary status, and plans frequently grant exceptions when medical necessity is clearly documented.

## Why This Is Appealable

Formulary decisions are administrative, not clinical. Your prescriber's judgment — backed by an applicable NCCN category listing — provides the clinical basis for a formulary exception. Many state insurance codes have explicit statutes requiring coverage of NCCN compendium drugs; Humana's own published exception process also typically allows formulary overrides on medical-necessity grounds. A formulary denial for an NCCN-supported agent should always be appealed.

## Federal Appeal Framework

Internal appeal / formulary exception request: These are often combined. File both simultaneously. Cite Humana's formulary exception policy and, if applicable, your state's oncology drug access statute.
External review (ACA §2719): After a final internal denial, an independent IRO can override a non-formulary determination if the drug is medically necessary. Standard window is approximately four months; expedited review is available for urgent situations.
ERISA §503 (employer plans): Request all documents used in the formulary and exception review.

## Documentation to Gather

1. Diagnosis and indication — pathology, staging, and molecular markers that link this specific drug to your diagnosis. 2. NCCN compendium printout — the applicable NCCN listing for this drug/indication from NCCN.org. 3. Formulary alternatives tried or contraindicated — documentation showing that formulary alternatives were tried and failed, are clinically inferior in your case, or are medically inappropriate. 4. Prescriber letter — a letter explicitly requesting a formulary exception, citing medical necessity and the NCCN listing. 5. State law citation — your insurance broker or patient advocate can identify any applicable state law requiring coverage of NCCN drugs.

## Criteria-Mapping Structure

Obtain Humana's formulary exception criteria from the plan documents or by calling Member Services. Build a checklist: each exception criterion on the left, the chart evidence supporting it on the right. Attach the NCCN printout, the prescriber letter, and records of any tried formulary alternatives as labeled exhibits.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Humana appeals

Other insurers on Off Label NCCN

Aetna denied as non-formulary of Off Label NCCN

Other denial reasons for Humana Off Label NCCN

denied as not medically necessary denied for failing step therapy denied for missing prior authorization denied as experimental or investigational denied as not FDA-approved for this use

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.